Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Camp4 Therapeutics (CAMP) Capital Leases (2023 - 2025)

Historic Capital Leases for Camp4 Therapeutics (CAMP) over the last 3 years, with Q3 2025 value amounting to $47000.0.

  • Camp4 Therapeutics' Capital Leases fell 4597.7% to $47000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $47000.0, marking a year-over-year decrease of 4597.7%. This contributed to the annual value of $70000.0 for FY2024, which is 5270.27% down from last year.
  • As of Q3 2025, Camp4 Therapeutics' Capital Leases stood at $47000.0, which was down 4597.7% from $59000.0 recorded in Q2 2025.
  • Camp4 Therapeutics' 5-year Capital Leases high stood at $148000.0 for Q4 2023, and its period low was $47000.0 during Q3 2025.
  • Its 3-year average for Capital Leases is $78166.7, with a median of $64500.0 in 2024.
  • In the last 5 years, Camp4 Therapeutics' Capital Leases tumbled by 5270.27% in 2024 and then plummeted by 4597.7% in 2025.
  • Over the past 3 years, Camp4 Therapeutics' Capital Leases (Quarter) stood at $148000.0 in 2023, then crashed by 52.7% to $70000.0 in 2024, then plummeted by 32.86% to $47000.0 in 2025.
  • Its last three reported values are $47000.0 in Q3 2025, $59000.0 for Q2 2025, and $58000.0 during Q1 2025.